Inhibrx Biosciences (NASDAQ:INBX) reported quarterly earnings of $125.48 per share. This is a 3011.37 percent increase over losses of $(4.31) per share from the same period last year. The company reported $100.00 thousand in sales this quarter. This is a 233.33 percent increase over sales of $30.00 thousand the same period last year.
Inhibrx Biosciences Q2 EPS $125.48, Sales $100.00K Up From $30.00K YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.